ArticleCancer cell international2026

CDK4 inhibition by luteolin enhances lenvatinib sensitivity in HCC via Wnt/β-catenin modulation.

Baohong Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.